Clinical trials
Active, not recruiting Biliary Tract Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
34 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2015 | 1 |
| 2016 | 1 |
| 2018 | 3 |
| 2019 | 4 |
| 2020 | 3 |
| 2021 | 3 |
| 2022 | 2 |
| 2023 | 6 |
| 2024 | 7 |
| 2025 | 2 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 34 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 6 |
| Asan Medical Center | 2 |
| Eli Lilly and Company | 2 |
| National Health Research Institutes, Taiwan | 2 |
| Akeso | 1 |
| Amgen | 1 |
| Ankara University | 1 |
| Astellas Pharma Global Development, Inc. | 1 |
| Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 1 |
| Compass Therapeutics | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Biliary Tract Neoplasms | 34 |
| Cholangiocarcinoma | 7 |
| Carcinoma, Non-Small-Cell Lung | 6 |
| Colorectal Neoplasms | 5 |
| Gallbladder Neoplasms | 5 |
| Stomach Neoplasms | 5 |
| Pancreatic Neoplasms | 4 |
| Carcinoma, Hepatocellular | 3 |
| Endometrial Neoplasms | 3 |
| Neuroendocrine Tumors | 3 |
Trials
Showing 26 to 34 of 34. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.